Jessica Maritza Guamán-Bautista

Mrs. Jessica Maritza Guamán-Bautista

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Carlos Barba-OstriaCarlos Barba-Ostria
Carlos Barba-Ostria
JGJessica Maritza Guamán-Bautista
Jessica Maritza Guamán-Bautista
ATAugusto Andrés Tosi
Augusto Andrés Tosi
Juan A. Puente-PinedaJuan A. Puente-Pineda
Juan A. Puente-Pineda
Melanie Aylin Cedeño ZambranoMelanie Aylin Cedeño Zambrano
Melanie Aylin Cedeño Zambrano
Linda GuamanLinda Guaman
Linda Guaman
Background: Andean plants are rich in bioactive compounds shaped by extreme environmental conditions, contributing to their antioxidant, antimicrobial, and anti-inflammatory properties. This review explores their phytochemical composition, biological activities, and therapeutic potential in modern medicine and nutrition of three plants of Andean origin. Methods: A literature review of peer-reviewed studies was conducted, focusing on key species such as quinoa (Chenopodium quinoa), amaranth (Amaranthus spp.), and lupin (Lupinus spp.), selected for this review due to their Andean origin, long-standing role in traditional diets, and growing scientific interest in their unique phytochemical profiles and therapeutic potential. This analysis covers their phytochemistry, bioactivities, and the influence of environmental factors on compound potency. Results: These Andean-origin plants contain flavonoids, terpenoids, alkaloids, and phenolic compounds that support antioxidant, antimicrobial, anti-inflammatory, and anticancer activities. High-altitude conditions enhance the biosynthesis of these bioactives, increasing their therapeutic value. Quinoa, amaranth, and lupin show strong potential for dietary and pharmaceutical applications, particularly in metabolic health and disease prevention. Additionally, preclinical studies and clinical trials have begun exploring the efficacy of these compounds in preventing and treating metabolic and chronic diseases. Conclusions: Andean plants are a valuable source of functional bioactive molecules with diverse health benefits. Future research should optimize cultivation strategies and explore novel applications in nutrition and medicine.

27 November 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
Carlos Barba-OstriaCarlos Barba-Ostria
Carlos Barba-Ostria
YCYenddy N. Carrero
Yenddy N. Carrero
JGJessica Maritza Guamán-Bautista
Jessica Maritza Guamán-Bautista
Orestes LópezOrestes López
Orestes López
CAChristian Aranda
Christian Aranda
Linda GuamanLinda Guaman
Linda Guaman
Objectives: This study investigates the biological activities of microencapsulated anthocyanins extracted from two Andean ancestral edible plants, Solanum tuberosum, and Zea mays, with a focus on their potential applications in functional foods and therapeutics. The primary objective was to evaluate their antioxidant, antimicrobial, and cytotoxic properties alongside structural and functional analyses of the microencapsulation process. Methods: Anthocyanins were extracted and microencapsulated using maltodextrin as a carrier. Fourier-transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM) were employed to analyze the stability and structure of the microencapsulated particles. The antioxidant, antimicrobial, and cytotoxic activities of the microencapsulated were assessed through established assays. Results:S. tuberosum exhibited superior antioxidant capacity and potent anticancer activity against HepG2 and THJ29T cell lines, while Z. mays demonstrated significant antimicrobial efficacy against multidrug-resistant bacterial strains and biofilm-forming pathogens. Fourier-transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM) confirmed the stabilization of anthocyanins within a maltodextrin matrix, enhancing their bioavailability and application potential. Conclusions: These results highlight the versatility of microencapsulated anthocyanins as bioactive agents for industrial and therapeutic applications. Future studies should explore in vivo validation and synergistic formulations to optimize their efficacy and broaden their use in nutraceutical and pharmaceutical fields.

27 March 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
ARArianna Mayorga Ramos
Arianna Mayorga Ramos
Johana Janina Zuñiga MirandaJohana Janina Zuñiga Miranda
Johana Janina Zuñiga Miranda
Elena Del Rocío Coyago CruzElena Del Rocío Coyago Cruz
Elena Del Rocío Coyago Cruz
JHJorge Heredia-Moya
Jorge Heredia-Moya
JGJessica Maritza Guamán-Bautista
Jessica Maritza Guamán-Bautista
Linda GuamanLinda Guaman
Linda Guaman
Macleania rupestris, a fruit-bearing species of the Ericaceae family, has traditionally been used for its potential medicinal properties. Background/Objectives: This study investigates the phytochemical composition and antimicrobial activity of M. rupestris fruit extract, focusing on its antibacterial, antibiofilm, and antifungal effects. Methods: M. rupestris (Kunth) A.C.Sm. berries (code: 4456, Herbario QUPS-Ecuador) were collected from the cloud forest Montano Alto, Cuenca-Ecuador, and the extract was obtained using an ethanolic-based extraction and chemically characterized. The antibacterial and antifungal activity of the fruit extract was assessed against seven multidrug-resistant bacteria strains and four fungal strains using the microdilution method. The biofilm inhibition potential was evaluated using a microplate assay with the crystal violet staining method. The antioxidant activity was evaluated using DPPH and ABTS assays. Results: The bioactive compounds showed 853.9 mg phenols/100 g DW, 573.2 mg organic acid/100 g DW, and 21.5 mg C-3-gl/100 g DW of anthocyanins. The antibacterial assays demonstrated significant inhibitory activity against Enterococcus faecalis, Enterococcus faecium, Escherichia coli, and Staphylococcus epidermidis, with MIC values ranging from 1.25 to 5 mg/mL. Additionally, the biofilm inhibition assays confirmed the potential of M. rupestris extract to disrupt bacterial biofilms, particularly in S. aureus and L. monocytogenes. Nevertheless, no significant antifungal activity was observed against Candida spp., suggesting selective antimicrobial properties. Finally, the antioxidant activity was strong (1.62 mmol TE/100 g DW by DPPH and 3.28 mmol TE/100 g DW by ABTS). Conclusions: These findings indicate that M. rupestris possesses promising antibacterial, antibiofilm, and antioxidant properties, which may be attributed to its phenolic and organic acid composition. Further fractionation and targeted bioassays are required to elucidate the specific bioactive compounds responsible for these effects and explore their potential applications in antimicrobial formulations.

19 August 2026 in Foods
Verified
Journal Article
Open access
PDF file
Carlos Barba-OstriaCarlos Barba-Ostria
Carlos Barba-Ostria
MBMaría José Barreno-Sánchez
María José Barreno-Sánchez
FSFabián Salazar-Garcés
Fabián Salazar-Garcés
JGJessica Maritza Guamán-Bautista
Jessica Maritza Guamán-Bautista
Linda GuamanLinda Guaman
Linda Guaman
Andean crops, including quinoa (Chenopodium quinoa), amaranth species including kiwicha (Amaranthus caudatus), chocho (Lupinus mutabilis), and cañihua (Chenopodium pallidicaule), constitute promising protein matrices for bioactive peptide generation by microbial fermentation and enzymatic proteolysis. These pseudocereals and legumes contain storage proteins, mainly 11S globulins and 2S albumins, enriched in lysine and sulfur-containing amino acids, and therefore provide suitable precursors for multifunctional peptides. In addition, secondary metabolites, such as quinoa saponins and chocho alkaloids, may influence proteolysis, peptide release, and peptide stability during fermentation. This review critically examines LAB fermentation as a food-grade strategy for bioactive peptide production from Andean crops. Evidence from enzymatic hydrolysis and simulated gastrointestinal digestion is included as complementary information and is discussed separately from fermentation-derived evidence. Reported activities include antioxidant, ACE-inhibitory, DPP-IV- and α-glucosidase-inhibitory, antimicrobial and anti-inflammatory activities. Particular attention is given to peptide generation, molecular-weight fractionation, peptidomic characterization, structure–activity relationships, simulated gastrointestinal digestion, and bioaccessibility. Most reported activities were measured in hydrolysates or molecular-weight fractions rather than in defined sequences, and individually validated peptides remain a minority. The strength of evidence differs markedly among crops: fermentation-derived data are more developed for quinoa and amaranth, whereas evidence for chocho and cañihua relies largely on enzymatic hydrolysis. Current limitations, including substrate variability, sensory acceptability, process standardization, peptide identification, bioavailability, and the lack of human validation studies, are also discussed. Andean crop proteins are promising precursors of functional peptide ingredients; however, peptide-specific bioavailability and human efficacy remain largely untested.

1 November 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Carlos Barba-OstriaCarlos Barba-Ostria
Carlos Barba-Ostria
Melanie Aylin Cedeño ZambranoMelanie Aylin Cedeño Zambrano
Melanie Aylin Cedeño Zambrano
Juan A. Puente-PinedaJuan A. Puente-Pineda
Juan A. Puente-Pineda
BZBelén Rebeca Cortez Zambrano
Belén Rebeca Cortez Zambrano
JGJessica Maritza Guamán-Bautista
Jessica Maritza Guamán-Bautista
Linda GuamanLinda Guaman
Linda Guaman
Antimicrobial resistance (AMR) and biofilm-associated infections represent major therapeutic challenges because they reduce antimicrobial susceptibility, promote persistence, and limit the effectiveness of conventional treatments. Phytochemicals offer a complementary strategy due to their multitarget antimicrobial and antibiofilm activities, including membrane disruption, oxidative stress induction, quorum-sensing interference, efflux-pump inhibition, and disruption of extracellular polymeric substances. However, their clinical application is frequently restricted by poor aqueous solubility, chemical instability, rapid degradation, limited bioavailability, and insufficient accumulation at infection sites. Encapsulation provides a means to overcome these limitations through physicochemical protection, controlled release, and improved local delivery. This review examines the main delivery platforms used to formulate antibacterial phytochemicals against multidrug-resistant and biofilm-associated bacterial pathogens, with emphasis on how carrier materials and formulation parameters influence antimicrobial and antibiofilm activity. Translational applications in antimicrobial coatings, medical devices, wound and burn infections, and combination therapies are critically discussed. Current limitations related to manufacturing scalability, reproducibility, safety, regulatory classification, methodological heterogeneity, and the limited progression from in vitro studies to clinically relevant models are also discussed. Overall, encapsulation can expand the therapeutic potential of phytochemicals, but future progress will depend on demonstrating reproducible advantages over free compounds through standardized formulation, appropriate controls, relevant preclinical models, and early integration of safety and regulatory requirements.